Amgen Inc AMGN on Monday released data from the Phase 3 FORTITUDE-101 trial of first-line bemarituzumab…
Continue ReadingTag: Gastric
The universal zero markup drug policy and gastric cancer hospitalization expenses: an analysis of trends and influencing factors in Shanghai from 2014 to 2021 | BMC Health Services Research
This study retrospectively analyzed the trends and influencing factors of hospitalization expenses for GC patients in…
Continue Reading
Gastric Motility Disorder Drugs Market Valued at USD 57.6
Gastric Motility Disorder Drugs Market The global gastric motility disorder drugs market is undergoing significant evolution,…
Continue Reading
Health expenditure trajectory and gastric cancer incidence in the National Health Insurance Senior Cohort: a nested case-control study | BMC Health Services Research
Balakrishnan M, George R, Sharma A, et al. Changing trends in stomach cancer throughout the world.…
Continue Reading
Progress Made for Gastric Cancer with FDA Approval of Tevimbra
The FDA has approved Tevimbra (tislelizumab-jsgr) for a second indication: in combination with platinum and fluoropyrimidine-based…
Continue Reading
Research: Gastric Bypass Advised for Severely Obese Patients
Gastric bypass is the most clinically and cost effective form of interventional surgery for people living…
Continue Reading